HB4132 would amend the Federal Food, Drug, and Cosmetic Act to allow required prescribing information for drugs to be provided electronically, with an option for prescribers and dispensers to receive paper copies. It requires HHS to issue final regulations within one year to implement the change and to ensure a pathway for obtaining paper labeling at no additional cost.
The bill also directs a public workshop within two years to discuss format, accessibility, and usability of prescribing information, and sets an effective date tied to enactment or final regulations.
At a Glance
What It Does
The bill amends section 502(f) to permit electronic-only prescribing information for drugs subject to 503(b)(1), while requiring that paper labeling remains available on request at no extra cost and that all legal labeling requirements are met. It also mandates regulatory guidance to implement the change and provide a path to paper copies from manufacturers or distributors.
Who It Affects
Prescribers, pharmacists, and drug distributors must adapt to electronic labeling while maintaining access to paper copies; drug manufacturers bear the responsibility to provide both digital and free-on-request paper labeling; health systems and EHR/EMR vendors will integrate digital labeling into workflows.
Why It Matters
This sets a regulatory pathway to modernize labeling delivery, potentially reducing printing costs and improving access to up-to-date information, while safeguarding clinician choice and patient safety through continued paper access when desired.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Prescription Information Modernization Act of 2025 changes how drug prescribing information is shared. It lets manufacturers provide prescribing information primarily through electronic means for drugs covered by current labeling requirements, but it requires that prescribers and dispensers can still receive paper copies on request at no extra cost.
The reform is not just about going online; it also creates a regulatory process. Within one year of enactment, the Secretary of Health and Human Services must issue final regulations to implement the change and to guide healthcare professionals on obtaining paper copies from manufacturers or distributors if they prefer.
The Act also directs a public workshop within two years to discuss how to optimize the format, accessibility, and usability of prescribing information, ensuring that the information remains practical for clinical use and patient safety.
The Five Things You Need to Know
The amendment to 502(f) allows electronic prescribing information with an opt-out option for paper labeling, preserving access for those who need it.
Within one year, the Secretary must issue final regulations implementing the amendment and provide instructions for obtaining paper copies from manufacturers or distributors at no extra cost.
Regulations must be designed to minimize adverse economic impacts on prescribers and dispensers.
A public workshop must be held within two years to discuss optimizing the format, accessibility, and usability of prescribing information.
The new labeling approach applies to drugs introduced or delivered for interstate commerce on or after the earlier of two years post-enactment or the final regulations.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Electronic labeling with opt-out for paper copies
This subsection amends the labeling regime to permit electronic availability of required prescribing information for drugs subject to 503(b)(1), while guaranteeing that manufacturers provide a paper copy option upon request at no extra cost. It clarifies that all applicable labeling requirements must still be met. The change creates a default digital-labeling pathway but preserves patient and clinician choice to receive paper labels when desired.
Rulemaking to implement amendment
This subsection directs the Secretary of Health and Human Services to issue final regulations within one year to implement the digital labeling amendment and to provide clear instructions on how professionals can obtain paper copies from manufacturers or distributors. The intent is to ensure a smooth transition, preserve reporting and safety standards, and address operational details for industry players.
Public workshop
Within two years, the Secretary, through the FDA Commissioner, must convene a public workshop with relevant stakeholders to discuss improvements to the format, accessibility, and usability of prescribing information. The workshop is aimed at collecting feedback on digital labeling practices and identifying practical enhancements for clinicians and patients.
Effective date
The amendment applies to drugs introduced or delivered for interstate commerce on the earlier of two years after enactment or the effective date of the final regulations implementing the amendment. This creates a concrete timeline for when digital labeling becomes the default while preserving access to paper copies during the transition.
Definition of drug
For purposes of this section, the term drug has the meaning provided in section 201 of the FD&C Act. This ensures consistency with existing statutory definitions and clarifies the scope of labeling changes to drugs (including biological products) subject to 503(b)(1).
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Practicing clinicians (physicians, nurse practitioners, physician assistants) receive streamlined access to up-to-date electronic labeling and retain paper copies when needed, preserving clinical workflow efficiency.
- Pharmacists and dispensing staff gain standardized electronic labeling and the option to retrieve paper labeling on demand, supporting accurate dispensing and patient counseling.
- Drug manufacturers and distributors can reduce printing and distribution costs while maintaining customer service by providing free-on-request paper copies.
- Health systems and hospitals can integrate digital labeling into electronic health records and pharmacy information systems, boosting consistency of information across care settings.
- Health information technology vendors can build and enhance tools that surface electronic prescribing information within clinical workflows and decision-support systems.
Who Bears the Cost
- Drug manufacturers and distributors bear initial and ongoing costs to implement and maintain electronic labeling systems and ensure timely provision of paper copies on request at no extra cost.
- Some health care providers may incur modest training and workflow adjustment costs as they adapt to integrated digital labeling in electronic systems.
- Regulatory and administrative costs associated with developing and updating final regulations to implement the amendment fall primarily on the federal agency administering the FD&C Act.
Key Issues
The Core Tension
Balancing the efficiency and consistency of digital labeling with the need to ensure universal, timely access to information and minimal cost burdens across diverse healthcare settings.
The shift to digital labeling raises practical questions about accessibility, equity, and cybersecurity. While the bill preserves a no-cost paper-label option on request, reliance on electronic labeling could create temporary frictions for practices with limited digital infrastructure or for patients who lack reliable access to electronic resources.
The requirement for prompt paper copies on request mitigates this risk but requires robust processes at the manufacturing and distribution levels to avoid delays. The economic impact on practitioners and dispensers is explicitly addressed, yet the real-world burden will hinge on how quickly and uniformly vendors implement the new standard and how smoothly paper-label fulfillment is executed.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.